NDC 0173-0892-42
Nucala 100 mg/mL
mepolizumab · INJECTION, SOLUTION
Nucala is a injection, solution containing mepolizumab at a strength of 100 mg/mL. Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- Nucala
- Generic Name
- mepolizumab
- NDC Code (Package)
0173-0892-42- NDC Code (Product)
0173-0892- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 100 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761122
- Drug Class
- Interleukin-5 Antagonist [EPC]
- Marketing Start
- 06/06/2019
Recall History
No Recall HistoryView Full Drug Page
Nucala — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.